The emergence of two microtubule-associated membrane scaffold proteins, STOM and KANK2, as top prioritized potential therapeutic targets for PSP, a primary tauopathy characterized by microtubule-associated protein tau neuropathology, is noteworthy. Here, MAPT is linked to tauopathy.